27252074|t|The Chinese Herbal Mixture Tien-Hsien Liquid Augments the Anticancer Immunity in Tumor Cell - Vaccinated Mice
27252074|a|Background The Chinese herbal mixture, Tien-Hsien liquid (THL), has been used as an anticancer dietary supplement for more than 20 years. Our previous studies have shown that THL can modulate immune response and inhibit tumor growth. In this study, we further evaluated the effect of THL on anticancer immune response in mice vaccinated with γ-ray - irradiated tumor cells. Methods The antitumor effect of THL was determined in mice vaccinated with low-tumorigenic CT-26-low colon cancer cells or γ-ray-irradiated high-tumorigenic CT-26-high colon cancer cells. The number of natural killer (NK) cells and T lymphocytes in the spleen was analyzed by flow cytometry. The tumor - killing activities of NK cells and cytotoxic T lymphocytes (CTLs) were analyzed by flow cytometry using YAC-1 and CT-26-high cells, respectively, as target cells. The levels of IFN-γ, IL-2, and TNF-α were determined by ELISA. Results THL suppressed the growth of CT-26-high tumor in mice previously vaccinated with low-tumorigenic CT-26-low cells or γ-irradiated CT-26-high cells. THL increased the populations of NK cells and CD4+ T lymphocytes in the spleen and enhanced the tumor - killing activities of NK cells and CTL in mice vaccinated with γ-irradiated CT-26-high cells. THL increased the production of IFN-γ, IL-2, and TNF-α in mice vaccinated with γ-irradiated CT-26-high cells. Conclusion THL can enhance the antitumor immune responses in mice vaccinated with killed tumor cells. These results suggest that THL may be used as a complementary medicine for cancer patients previously treated with killed tumor cell vaccines, radiotherapy, or chemotherapy.
27252074	27	44	Tien-Hsien Liquid	T103	UMLS:C1528399
27252074	69	77	Immunity	T038	UMLS:C0020964
27252074	81	91	Tumor Cell	T017	UMLS:C0597032
27252074	94	104	Vaccinated	T033	UMLS:C1116171
27252074	105	109	Mice	T204	UMLS:C0025929
27252074	149	166	Tien-Hsien liquid	T103	UMLS:C1528399
27252074	168	171	THL	T103	UMLS:C1528399
27252074	205	223	dietary supplement	T168	UMLS:C0242295
27252074	261	268	studies	T062	UMLS:C2603343
27252074	285	288	THL	T103	UMLS:C1528399
27252074	293	301	modulate	T082	UMLS:C0443264
27252074	302	317	immune response	T038	UMLS:C0301872
27252074	352	357	study	T062	UMLS:C2603343
27252074	370	379	evaluated	T058	UMLS:C0220825
27252074	394	397	THL	T103	UMLS:C1528399
27252074	412	427	immune response	T038	UMLS:C0301872
27252074	431	435	mice	T204	UMLS:C0025929
27252074	436	446	vaccinated	T033	UMLS:C1116171
27252074	471	482	tumor cells	T017	UMLS:C0597032
27252074	516	519	THL	T103	UMLS:C1528399
27252074	538	542	mice	T204	UMLS:C0025929
27252074	543	553	vaccinated	T033	UMLS:C1116171
27252074	559	603	low-tumorigenic CT-26-low colon cancer cells	T017	UMLS:C0085983
27252074	607	623	γ-ray-irradiated	T058	UMLS:C2985557
27252074	624	670	high-tumorigenic CT-26-high colon cancer cells	T017	UMLS:C0085983
27252074	686	711	natural killer (NK) cells	T017	UMLS:C0022688
27252074	716	729	T lymphocytes	T017	UMLS:C0039194
27252074	737	743	spleen	T017	UMLS:C0037993
27252074	748	756	analyzed	T062	UMLS:C0936012
27252074	760	774	flow cytometry	T058	UMLS:C0016263
27252074	780	785	tumor	T038	UMLS:C0027651
27252074	788	795	killing	T038	UMLS:C0599733
27252074	810	818	NK cells	T017	UMLS:C0022688
27252074	823	846	cytotoxic T lymphocytes	T017	UMLS:C0039195
27252074	848	852	CTLs	T017	UMLS:C0039195
27252074	859	867	analyzed	T062	UMLS:C0936012
27252074	871	885	flow cytometry	T058	UMLS:C0016263
27252074	892	897	YAC-1	T017	UMLS:C0085983
27252074	902	918	CT-26-high cells	T017	UMLS:C0085983
27252074	944	949	cells	T017	UMLS:C0007634
27252074	965	970	IFN-γ	T103	UMLS:C0021745
27252074	972	976	IL-2	T103	UMLS:C0021756
27252074	982	987	TNF-α	T103	UMLS:C1456820
27252074	1007	1012	ELISA	T058	UMLS:C0014441
27252074	1022	1025	THL	T103	UMLS:C1528399
27252074	1041	1047	growth	T038	UMLS:C0018270
27252074	1051	1067	CT-26-high tumor	T017	UMLS:C0085983
27252074	1071	1075	mice	T204	UMLS:C0025929
27252074	1087	1097	vaccinated	T033	UMLS:C1116171
27252074	1103	1134	low-tumorigenic CT-26-low cells	T017	UMLS:C0085983
27252074	1138	1150	γ-irradiated	T058	UMLS:C2985557
27252074	1151	1167	CT-26-high cells	T017	UMLS:C0085983
27252074	1169	1172	THL	T103	UMLS:C1528399
27252074	1202	1210	NK cells	T017	UMLS:C0022688
27252074	1215	1233	CD4+ T lymphocytes	T017	UMLS:C0039215
27252074	1241	1247	spleen	T017	UMLS:C0037993
27252074	1265	1270	tumor	T038	UMLS:C0027651
27252074	1273	1280	killing	T038	UMLS:C0599733
27252074	1295	1303	NK cells	T017	UMLS:C0022688
27252074	1308	1311	CTL	T017	UMLS:C0039195
27252074	1315	1319	mice	T204	UMLS:C0025929
27252074	1320	1330	vaccinated	T033	UMLS:C1116171
27252074	1336	1348	γ-irradiated	T058	UMLS:C2985557
27252074	1349	1365	CT-26-high cells	T017	UMLS:C0085983
27252074	1367	1370	THL	T103	UMLS:C1528399
27252074	1399	1404	IFN-γ	T103	UMLS:C0021745
27252074	1406	1410	IL-2	T103	UMLS:C0021756
27252074	1416	1421	TNF-α	T103	UMLS:C1456820
27252074	1425	1429	mice	T204	UMLS:C0025929
27252074	1430	1440	vaccinated	T033	UMLS:C1116171
27252074	1446	1458	γ-irradiated	T058	UMLS:C2985557
27252074	1459	1475	CT-26-high cells	T017	UMLS:C0085983
27252074	1488	1491	THL	T103	UMLS:C1528399
27252074	1518	1534	immune responses	T038	UMLS:C0301872
27252074	1538	1542	mice	T204	UMLS:C0025929
27252074	1543	1553	vaccinated	T033	UMLS:C1116171
27252074	1566	1577	tumor cells	T017	UMLS:C0597032
27252074	1606	1609	THL	T103	UMLS:C1528399
27252074	1627	1649	complementary medicine	T091	UMLS:C1148474
27252074	1654	1660	cancer	T038	UMLS:C0006826
27252074	1694	1720	killed tumor cell vaccines	T103	UMLS:C0376659
27252074	1722	1734	radiotherapy	T058	UMLS:C1522449
27252074	1739	1751	chemotherapy	T058	UMLS:C3665472